Authors: Robinson, RP Laird, ER Donahue, KM Lopresti-Morrow, LL Mitchell, PG Reese, MR Reeves, LM Rouch, AI Stam, EJ Yocum, SA

Citation: Rp. Robinson et al., Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors, BIOORG MED, 11(9), 2001, pp. 1211-1213

Authors: Robinson, RP Laird, ER Blake, JF Bordner, J Donahue, KM Lopresti-Morrow, LL Mitchell, PG Reese, MR Reeves, LM Stam, EJ Yocum, SA

Citation: Rp. Robinson et al., Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold, J MED CHEM, 43(12), 2000, pp. 2293-2296

Authors: Reiter, LA Rizzi, JP Pandit, J Lasut, MJ McGahee, SM Parikh, VD Blake, JF Danley, DE Laird, ER Lopez-Anaya, A Lopresti-Morrow, LL Mansour, MN Martinelli, GJ Mitchell, PG Owens, BS Pauly, TA Reeves, LM Schulte, GK Yocum, SA

Citation: La. Reiter et al., Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S-2 pocket, BIOORG MED, 9(2), 1999, pp. 127-132